Cannabis Use in Autism: Reasons for Concern about Risk for Psychosis

Healthcare (Basel). 2022 Aug 16;10(8):1553. doi: 10.3390/healthcare10081553.

Abstract

Being particularly vulnerable to the pro-psychotic effects of cannabinoid exposure, autism spectrum individuals present with an increased risk of psychosis, which may be passed on to their own children. More specifically, cannabis exposure among autism spectrum individuals seems to exert disruptive epigenetic effects that can be intergenerationally inherited in brain areas which play a critical role in schizophrenia pathophysiology. Additionally, because of such cannabinoid-induced epigenetic effects, autism candidate genes present with bivalent chromatin markings which make them more vulnerable to subsequent disruption, possibly leading to psychosis onset later in life. Thus, findings support a developmental trajectory between autism and psychosis, as per endocannabinoid system modulation. However, such evidence has not received the attention it deserves.

Keywords: cannabinoids; mental health services; neurodevelopment; prevention; schizophrenia.

Grants and funding

This research received no external funding.